{"parse":{"title":"Inverse benefit law","pageid":31345445,"revid":857434371,"text":{"*":"<div class=\"mw-parser-output\"><p>The <b>inverse benefit law</b> states that the ratio of benefits to harms among patients taking new <a href=\"/wiki/Drug\" title=\"Drug\">drugs</a> tends to vary inversely with how extensively a drug is <a href=\"/wiki/Marketed\" class=\"mw-redirect\" title=\"Marketed\">marketed</a>. Two Americans, Howard Brody and Donald Light, have defined the inverse benefit law, inspired by <a href=\"/wiki/Julian_Tudor_Hart\" title=\"Julian Tudor Hart\">Tudor Hart</a>'s <a href=\"/wiki/Inverse_care_law\" title=\"Inverse care law\">inverse care law</a>.<sup id=\"cite_ref-pmid21233426_1-0\" class=\"reference\"><a href=\"#cite_note-pmid21233426-1\">&#91;1&#93;</a></sup>\n</p><p>A drug <a href=\"/wiki/Effective\" class=\"mw-redirect\" title=\"Effective\">effective</a> for a serious <a href=\"/wiki/Disorder_(medicine)\" class=\"mw-redirect\" title=\"Disorder (medicine)\">disorder</a> is less and less effective as it is promoted for milder cases and for other conditions for which the drug was not approved. Although <a href=\"/wiki/Effectiveness\" title=\"Effectiveness\">effectiveness</a> becomes more diluted, the risks of harmful <a href=\"/wiki/Side_effects\" class=\"mw-redirect\" title=\"Side effects\">side effects</a> persist, and thus the benefit-harm ratio worsens as a drug is <a href=\"/wiki/Marketing\" title=\"Marketing\">marketed</a> more widely. The inverse benefit law highlights the need for <a href=\"/wiki/Comparative_effectiveness_research\" title=\"Comparative effectiveness research\">comparative effectiveness research</a> and other reforms to improve <a href=\"/wiki/Evidence-based_medicine\" title=\"Evidence-based medicine\">evidence-based</a> prescribing.<sup id=\"cite_ref-pmid21233426_1-1\" class=\"reference\"><a href=\"#cite_note-pmid21233426-1\">&#91;1&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#State_of_affairs\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">State of affairs</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Impact\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Impact</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#See_also\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#References\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#Bibliography\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Bibliography</span></a></li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#External_links\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"State_of_affairs\">State of affairs</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Inverse_benefit_law&amp;action=edit&amp;section=1\" title=\"Edit section: State of affairs\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The law is manifested through 6 basic marketing strategies:\n</p>\n<ul><li>reducing thresholds for diagnosing disease,</li>\n<li>relying on surrogate endpoints,</li>\n<li>exaggerating <a href=\"/wiki/Safety\" title=\"Safety\">safety</a> claims,</li>\n<li>exaggerating <a href=\"/wiki/Efficacy\" title=\"Efficacy\">efficacy</a> claims,</li>\n<li><a href=\"/wiki/Disease_mongering\" title=\"Disease mongering\">creating new diseases</a>,</li>\n<li>encouraging unapproved uses.</li></ul>\n<h2><span class=\"mw-headline\" id=\"Impact\">Impact</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Inverse_benefit_law&amp;action=edit&amp;section=2\" title=\"Edit section: Impact\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>This is the reason why organizations like \"Worst Pill, Best Pill\" <sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup> recommend not to use/prescribe new medications before being in the market for at least ten years (except in the case of important new drugs that treat previously unsolved problems).\n</p><p>Agencies of drugs, committee of ethics and organizations of patients' safety should consider: \n</p>\n<ul><li>Requiring that clinical trials run long enough to pick up evidence of side effects and record all adverse reactions, including in subjects who drop out.<sup id=\"cite_ref-pmid10328077_3-0\" class=\"reference\"><a href=\"#cite_note-pmid10328077-3\">&#91;3&#93;</a></sup></li>\n<li>Paying companies more for new drugs in proportion to how much better they are for patients than existing drugs, and marketing according to the value of the new drugs (ratio of benefits to harms and marketing).<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup></li>\n<li>Considering that market could be a force against the best use of medications.<sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup></li></ul>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Inverse_benefit_law&amp;action=edit&amp;section=3\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"div-col columns column-width\" style=\"-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em;\">\n<ul><li><a href=\"/wiki/Disease_mongering\" title=\"Disease mongering\">Disease mongering</a></li>\n<li><a href=\"/wiki/Health_policy\" title=\"Health policy\">Health policy</a></li>\n<li><a href=\"/wiki/Inverse_care_law\" title=\"Inverse care law\">Inverse care law</a></li>\n<li><a href=\"/wiki/Medicalization\" title=\"Medicalization\">Medicalization</a></li>\n<li><a href=\"/wiki/Patient_safety\" title=\"Patient safety\">Patient safety</a></li>\n<li><a href=\"/wiki/Pharmaceutical_company\" class=\"mw-redirect\" title=\"Pharmaceutical company\">Pharmaceutical company</a></li>\n<li><a href=\"/wiki/Pharmaceutical_marketing\" title=\"Pharmaceutical marketing\">Pharmaceutical marketing</a></li>\n<li><a href=\"/wiki/Public_health\" title=\"Public health\">Public health</a></li>\n<li><a href=\"/wiki/Quaternary_prevention\" title=\"Quaternary prevention\">Quaternary prevention</a></li>\n<li><a href=\"/wiki/Medical_science_liaison\" title=\"Medical science liaison\">Medical science liaison</a></li></ul>\n</div>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Inverse_benefit_law&amp;action=edit&amp;section=4\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap\"><ol class=\"references\">\n<li id=\"cite_note-pmid21233426-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid21233426_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid21233426_1-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Brody, Howard; Light, Donald W (2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3036704\">\"The Inverse Benefit Law: How Drug Marketing Undermines Patient Safety and Public Health\"</a>. <i>American Journal of Public Health</i>. <b>101</b> (3): 399\u2013404. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2105/AJPH.2010.199844\">10.2105/AJPH.2010.199844</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3036704\">3036704</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21233426\">21233426</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Public+Health&amp;rft.atitle=The+Inverse+Benefit+Law%3A+How+Drug+Marketing+Undermines+Patient+Safety+and+Public+Health&amp;rft.volume=101&amp;rft.issue=3&amp;rft.pages=399-404&amp;rft.date=2011&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3036704&amp;rft_id=info%3Apmid%2F21233426&amp;rft_id=info%3Adoi%2F10.2105%2FAJPH.2010.199844&amp;rft.aulast=Brody&amp;rft.aufirst=Howard&amp;rft.au=Light%2C+Donald+W&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3036704&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AInverse+benefit+law\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.worstpills.org/\">\"Worst Pill, Best Pill. Public Citizen's Health Research Group\"</a>. Worstpills.org<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2014-02-17</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Worst+Pill%2C+Best+Pill.+Public+Citizen%27s+Health+Research+Group&amp;rft.pub=Worstpills.org&amp;rft_id=http%3A%2F%2Fwww.worstpills.org%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AInverse+benefit+law\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid10328077-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10328077_3-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wood, Alastair J. J (1999). \"The Safety of New Medicines\". <i>JAMA</i>. <b>281</b> (18): 1753\u20134. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.281.18.1753\">10.1001/jama.281.18.1753</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10328077\">10328077</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=The+Safety+of+New+Medicines&amp;rft.volume=281&amp;rft.issue=18&amp;rft.pages=1753-4&amp;rft.date=1999&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.281.18.1753&amp;rft_id=info%3Apmid%2F10328077&amp;rft.aulast=Wood&amp;rft.aufirst=Alastair+J.+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AInverse+benefit+law\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://english.prescrire.org/en/81/168/46799/0/NewsDetails.aspx\">\"Astellas' lawsuit against Prescrire: French court rules that Prescrire did not \"denigrate\" Protopic\u00b0 (tacrolimus). Prescrire. 2 March 2011\"</a>. English.prescrire.org. 2011-03-02<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2014-02-17</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Astellas%27+lawsuit+against+Prescrire%3A+French+court+rules+that+Prescrire+did+not+%22denigrate%22+Protopic%C2%B0+%28tacrolimus%29.+Prescrire.+2+March+2011&amp;rft.pub=English.prescrire.org&amp;rft.date=2011-03-02&amp;rft_id=http%3A%2F%2Fenglish.prescrire.org%2Fen%2F81%2F168%2F46799%2F0%2FNewsDetails.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AInverse+benefit+law\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.actasanitaria.com/el-mirador-de-juan-gervas-garum/\">G\u00e9rvas J. Garum. Acta Sanitaria. 07/03/2011.</a></span>\n</li>\n</ol></div></div>\n<h2><span class=\"mw-headline\" id=\"Bibliography\">Bibliography</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Inverse_benefit_law&amp;action=edit&amp;section=5\" title=\"Edit section: Bibliography\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.pharmamyths.net\">Light DW (Editor). The Risks of Prescription Drugs. New York: Columbia University Press; 2010.</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20101225093331/http://www.jameslindlibrary.org/pdf/testing-treatments.pdf\">Evans I, Thornton H, Chalmers I. Testing Treatments: Better Research for Better Healthcare. London: Pinter &amp; Martin Ltd; 2010.</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Inverse_benefit_law&amp;action=edit&amp;section=6\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.pharmamyths.net/_the_inverse_benefit_law__105485.htm\">Donald W. Light</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.equipocesca.org\">Equipo CESCA</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.healthyskepticism.org/global/\">Healthy Skepticism</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.worstpills.org\">Worst Pills, Best Pills</a></li></ul>\n\n<!-- \nNewPP limit report\nParsed by mw1282\nCached time: 20180831173242\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.104 seconds\nReal time usage: 0.132 seconds\nPreprocessor visited node count: 335/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 7976/2097152 bytes\nTemplate argument size: 182/2097152 bytes\nHighest expansion depth: 7/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 6113/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.036/10.000 seconds\nLua memory usage: 2.11 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%   98.846      1 -total\n 70.47%   69.657      1 Template:Reflist\n 43.96%   43.448      2 Template:Cite_journal\n 26.14%   25.843      1 Template:Col_div\n 11.15%   11.021      2 Template:Cite_web\n  3.14%    3.105      1 Template:Colend\n  2.88%    2.844      2 Template:Main_other\n  1.93%    1.911      1 Template:Column-width\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:31345445-0!canonical and timestamp 20180831173251 and revision id 857434371\n -->\n</div>"},"langlinks":[{"lang":"ar","url":"https://ar.wikipedia.org/wiki/%D9%82%D8%A7%D9%86%D9%88%D9%86_%D8%A7%D9%84%D9%81%D8%A7%D8%A6%D8%AF%D8%A9_%D8%A7%D9%84%D8%B9%D9%83%D8%B3%D9%8A%D8%A9","langname":"Arabic","autonym":"\u0627\u0644\u0639\u0631\u0628\u064a\u0629","*":"\u0642\u0627\u0646\u0648\u0646 \u0627\u0644\u0641\u0627\u0626\u062f\u0629 \u0627\u0644\u0639\u0643\u0633\u064a\u0629"},{"lang":"ca","url":"https://ca.wikipedia.org/wiki/Llei_de_beneficis_inversos","langname":"Catalan","autonym":"catal\u00e0","*":"Llei de beneficis inversos"},{"lang":"es","url":"https://es.wikipedia.org/wiki/Ley_de_beneficios_inversos","langname":"Spanish","autonym":"espa\u00f1ol","*":"Ley de beneficios inversos"},{"lang":"zh","url":"https://zh.wikipedia.org/wiki/%E9%80%86%E5%90%91%E8%8E%B7%E7%9B%8A%E6%B3%95%E5%88%99","langname":"Chinese","autonym":"\u4e2d\u6587","*":"\u9006\u5411\u83b7\u76ca\u6cd5\u5219"}],"categories":[{"sortkey":"","*":"Pharmaceutics"},{"sortkey":"","*":"Health_economics"},{"sortkey":"","*":"Pharmaceutical_industry"}],"links":[{"ns":0,"exists":"","*":"Comparative effectiveness research"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Disease mongering"},{"ns":0,"exists":"","*":"Disorder (medicine)"},{"ns":0,"exists":"","*":"Drug"},{"ns":0,"exists":"","*":"Effective"},{"ns":0,"exists":"","*":"Effectiveness"},{"ns":0,"exists":"","*":"Efficacy"},{"ns":0,"exists":"","*":"Evidence-based medicine"},{"ns":0,"exists":"","*":"Health policy"},{"ns":0,"exists":"","*":"Inverse care law"},{"ns":0,"exists":"","*":"Julian Tudor Hart"},{"ns":0,"exists":"","*":"Marketed"},{"ns":0,"exists":"","*":"Marketing"},{"ns":0,"exists":"","*":"Medical science liaison"},{"ns":0,"exists":"","*":"Medicalization"},{"ns":0,"exists":"","*":"Patient safety"},{"ns":0,"exists":"","*":"Pharmaceutical company"},{"ns":0,"exists":"","*":"Pharmaceutical marketing"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Public health"},{"ns":0,"exists":"","*":"Quaternary prevention"},{"ns":0,"exists":"","*":"Safety"},{"ns":0,"exists":"","*":"Side effects"}],"templates":[{"ns":10,"exists":"","*":"Template:Col div"},{"ns":10,"exists":"","*":"Template:Div col"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Colend"},{"ns":10,"exists":"","*":"Template:Div col end"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"}],"images":["Lock-green.svg"],"externallinks":["//www.ncbi.nlm.nih.gov/pmc/articles/PMC3036704","//doi.org/10.2105/AJPH.2010.199844","//www.ncbi.nlm.nih.gov/pubmed/21233426","http://www.worstpills.org/","//doi.org/10.1001/jama.281.18.1753","//www.ncbi.nlm.nih.gov/pubmed/10328077","http://english.prescrire.org/en/81/168/46799/0/NewsDetails.aspx","http://www.actasanitaria.com/el-mirador-de-juan-gervas-garum/","http://www.pharmamyths.net","https://web.archive.org/web/20101225093331/http://www.jameslindlibrary.org/pdf/testing-treatments.pdf","http://www.pharmamyths.net/_the_inverse_benefit_law__105485.htm","http://www.equipocesca.org","http://www.healthyskepticism.org/global/","http://www.worstpills.org"],"sections":[{"toclevel":1,"level":"2","line":"State of affairs","number":"1","index":"1","fromtitle":"Inverse_benefit_law","byteoffset":1253,"anchor":"State_of_affairs"},{"toclevel":1,"level":"2","line":"Impact","number":"2","index":"2","fromtitle":"Inverse_benefit_law","byteoffset":1565,"anchor":"Impact"},{"toclevel":1,"level":"2","line":"See also","number":"3","index":"3","fromtitle":"Inverse_benefit_law","byteoffset":3200,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"4","index":"4","fromtitle":"Inverse_benefit_law","byteoffset":3500,"anchor":"References"},{"toclevel":1,"level":"2","line":"Bibliography","number":"5","index":"5","fromtitle":"Inverse_benefit_law","byteoffset":3530,"anchor":"Bibliography"},{"toclevel":1,"level":"2","line":"External links","number":"6","index":"6","fromtitle":"Inverse_benefit_law","byteoffset":3910,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Inverse benefit law","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q3774474"}]}}